PODD: Insulet Corporation Company Profile & Statistics

About

Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas.

Info & Links

CEO

James R. Hollingshead

Headquarters

100 NAGOG PARK
ACTON, MA 01720, UNITED STATES

Auditor

GRANT THORNTON LLP

Share holders

Employees

3,900

Insulet Corporation Statistics

Valuation Measures

Market Capitalization²

18.80B

Enterprise Value

19.23B

Enterprise Value/EBITDA(ttm)

49.34

Price to Earnings Ratio(ttm)

86.57

Price to Sales(ttm)

9.76

Price to Book(mrq)

18.08

Price to Cash(ytd)

75.96

Profitability

Gross Margin(ttm)

69.66%

Operating Margin(ttm)

11.44%

Profit Margin(ttm)

20.34%

Return on Equity(ttm)

24.46%

Return on Invested Capital(ttm)

17.54%

Return on Assets(ttm)

8.33%

Income Statement

Revenue(ttm)

2.07B

Revenue Per Share(ttm)

29.50

Gross Profit(ttm)

1.45B

EBITDA(ttm)³

389.70M

Net Income Available to Common(ttm)

418.30M

Diluted EPS(ttm)

5.79

Share Statistics

Beta (5Y Monthly)

1.23

52-Week Change

46.91%

S&P 500 52-Week Change

17.49%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

70.23M

Dividend Yield

0.00%

Float⁴

69.81M

% Held by Insiders

0.47%

% Held by Institutions

Balance Sheet

Total Cash(mrq)

953.40M

Total Cash Per Share(mrq)

13.58

Total Debt(mrq)

1.38B

Total Debt/Equity(mrq)

113.89%

Current Ratio(mrq)

3.58%

Quick Ratio(mrq)

2.80%

Book Value Per Share(mrq)

17.26

Cash Flow

Operating Cash Flow Per Share(ytd)

5.82

Free Cash Flow(ytd)

305.40M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

PODD

Insulet Corporation

Insulet Corporation Profile